Evidence map›Paper›PMID 33918954›Full record

ArticleMicroorganisms2021

Drug-Induced Lipid Remodeling in

Sneider Alexander Gutierrez Guarnizo, Elena B Tikhonova, Masoud Zabet-Moghaddam, Kai Zhang, Carlos Muskus, Andrey L Karamyshev, Zemfira N Karamysheva

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular Mechanisms of Drug Resistance inPathogens (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Article
  7. Fatty Acid Composition and Metabolism inInternational journal of molecular sciences · 2023
    Review
  8. Article
  9. Fatty Acid Profiles ofPathogens (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sneider Alexander Gutierrez GuarnizoDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0001-9329-0067
Elena B TikhonovaDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Masoud Zabet-MoghaddamCenter for Biotechnology and Genomics, Texas Tech University, Lubbock, TX 79409, USA.
Kai ZhangDepartment of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA.
Carlos MuskusPrograma de Estudio y Control de Enfermedades Tropicales, Facultad de medicina, Universidad de Antioquia, Medellín 050010, Colombia.
Andrey L KaramyshevDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Zemfira N KaramyshevaDepartment of Biological Sciences, Texas Tech University, Lubbock, TX 79409, USA.
Texas Tech University · USUniversidad de Antioquia · CO

Funding

Start-up funds from Texas Tech University Health Sciences Center to A.L.K. No grant numberThe program supported by Minciencias and the Department of Tolima, Colombia Program 755-2016
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimony resistancedrug resistance biomarkersLeishmanialeishmaniasis treatmentlipidomiclipid remodelingresistance phenotypestherapeutic targets

Identifiers

PMID33918954
PMCPMC8068835
OpenAlexW3154671028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.